Literature DB >> 27324391

Perspectives in Diagnosis and Treatment of Rabies Viral Encephalitis: Insights from Pathogenesis.

Anita Mahadevan1, M S Suja2, Reeta S Mani3, Susarala K Shankar2.   

Abstract

Rabies viral encephalitis, though one of the oldest recognized infectious disease of humans, remains an incurable, fatal encephalomyelitis, despite advances in understanding of its pathobiology. Advances in science have led us on the trail of the virus in the host, but the sanctuaries in which the virus remains hidden for its survival are unknown. Insights into host-pathogen interactions have facilitated evolving immunologic therapeutic strategies, though we are far from a cure. Most of the present-day knowledge has evolved from in vitro studies using fixed (attenuated) laboratory strains that may not be applicable in the clinical setting. Much remains to be unraveled about this elusive virus. This review attempts to re-examine the current advances in understanding of the pathobiology of the rabies virus that modulate the diagnosis, treatment, and prevention of this fatal disease.

Entities:  

Keywords:  Apoptosis; Negri bodies; Neurovirulence; Pathogenesis; Rabies; Survival

Mesh:

Year:  2016        PMID: 27324391      PMCID: PMC4965414          DOI: 10.1007/s13311-016-0452-4

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  148 in total

1.  The distribution of Challenge virus standard rabies virus versus skunk street rabies virus in the brains of experimentally infected rabid skunks.

Authors:  N L Smart; K M Charlton
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  PATHOGENESIS OF RABIES.

Authors:  D J DEAN; W M EVANS; R C MCCLURE
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

3.  Comparative pathogenesis of recombinant rabies vaccine strain SAD-L16 and SAD-D29 with replacement of Arg333 in the glycoprotein after peripheral inoculation of neonatal mice: less neurovirulent strain is a stronger inducer of neuronal apoptosis.

Authors:  Alan C Jackson; Pamini Rasalingam; Simon C Weli
Journal:  Acta Neuropathol       Date:  2006-02-02       Impact factor: 17.088

4.  Pituitary cachexia after rabies encephalitis.

Authors:  K V S Hari Kumar; F M H Ahmad; Vijay Dutta
Journal:  Neurol India       Date:  2015 Mar-Apr       Impact factor: 2.117

5.  The histopathogenesis of paralytic rabies in six-week-old C57BL/6J mice following inoculation of the CVS-11 strain into the right triceps surae muscle.

Authors:  Chun-Ho Park; Mariko Kondo; Satoshi Inoue; Akira Noguchi; Toshifumi Oyamada; Hiroyasu Yoshikawa; Akio Yamada
Journal:  J Vet Med Sci       Date:  2006-06       Impact factor: 1.267

6.  Partial recovery from rabies in a nine-year-old boy.

Authors:  L Alvarez; R Fajardo; E Lopez; R Pedroza; T Hemachudha; N Kamolvarin; G Cortes; G M Baer
Journal:  Pediatr Infect Dis J       Date:  1994-12       Impact factor: 2.129

7.  Apoptotic cell death in experimental rabies in suckling mice.

Authors:  A C Jackson; H Park
Journal:  Acta Neuropathol       Date:  1998-02       Impact factor: 17.088

8.  Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures.

Authors:  K Morimoto; D C Hooper; S Spitsin; H Koprowski; B Dietzschold
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  Structural abnormalities in neurons are sufficient to explain the clinical disease and fatal outcome of experimental rabies in yellow fluorescent protein-expressing transgenic mice.

Authors:  Courtney A Scott; John P Rossiter; R David Andrew; Alan C Jackson
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

10.  Cell to cell transmission of virus in the central nervous system. II. Experimental rabies in mouse.

Authors:  Y Iwasaki; H F Clark
Journal:  Lab Invest       Date:  1975-10       Impact factor: 5.662

View more
  12 in total

1.  Integrin β1 Promotes Peripheral Entry by Rabies Virus.

Authors:  Lei Shuai; Jinliang Wang; Dandan Zhao; Zhiyuan Wen; Jinying Ge; Xijun He; Xijun Wang; Zhigao Bu
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

2.  Safety and efficacy of rabies immunoglobulin in pediatric patients with suspected exposure.

Authors:  Nicholas Hobart-Porter; Michal Stein; Naveh Toh; Novinyo Amega; Huy-Binh Nguyen; James Linakis
Journal:  Hum Vaccin Immunother       Date:  2021-02-09       Impact factor: 4.526

Review 3.  Lyssaviruses and rabies: current conundrums, concerns, contradictions and controversies.

Authors:  Charles Rupprecht; Ivan Kuzmin; Francois Meslin
Journal:  F1000Res       Date:  2017-02-23

Review 4.  COVID-19 in the Age of Artificial Intelligence: A Comprehensive Review.

Authors:  Jawad Rasheed; Akhtar Jamil; Alaa Ali Hameed; Fadi Al-Turjman; Ahmad Rasheed
Journal:  Interdiscip Sci       Date:  2021-04-22       Impact factor: 3.492

5.  Updates on Rabies virus disease: is evolution toward "Zombie virus" a tangible threat?

Authors:  Giuseppe Lippi; Gianfranco Cervellin
Journal:  Acta Biomed       Date:  2021-02-04

6.  Machine Learning Identifies Cellular and Exosomal MicroRNA Signatures of Lyssavirus Infection in Human Stem Cell-Derived Neurons.

Authors:  Ryan J Farr; Nathan Godde; Christopher Cowled; Vinod Sundaramoorthy; Diane Green; Cameron Stewart; John Bingham; Carmel M O'Brien; Megan Dearnley
Journal:  Front Cell Infect Microbiol       Date:  2021-12-24       Impact factor: 5.293

Review 7.  The Imperative of Palliation in the Management of Rabies Encephalomyelitis.

Authors:  Mary Warrell; David A Warrell; Arnaud Tarantola
Journal:  Trop Med Infect Dis       Date:  2017-10-04

8.  Forecasting delay times in post-exposure prophylaxis to human animal bite injuries in Central Iran: A decision tree analysis.

Authors:  Amir Hamta; Abedin Saghafipour; Seyed Abbas Hosseinalipour; Fatemeh Rezaei
Journal:  Vet World       Date:  2019-07-05

9.  Safety and efficacy results of simulated post-exposure prophylaxis with human immune globulin (HRIG; KEDRAB) co-administered with active vaccine in healthy subjects: a comparative phase 2/3 trial.

Authors:  Mark A Matson; Eran Schenker; Michal Stein; Vladislava Zamfirova; Huy-Binh Nguyen; Garrett E Bergman
Journal:  Hum Vaccin Immunother       Date:  2019-09-24       Impact factor: 3.452

Review 10.  Acute RNA Viral Encephalomyelitis and the Role of Antibodies in the Central Nervous System.

Authors:  Maggie L Bartlett; Diane E Griffin
Journal:  Viruses       Date:  2020-09-05       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.